01875 東曜藥業-B
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
09/04/2026WuXi XDC Cayman Inc.1201(L)-6,216,540(L)468,853,184(L)60.67
09/04/2026WuXi Biologics (Cayman) Inc.1201(L)-6,216,540(L)468,853,184(L)60.67
31/03/2026Advantech Capital Investment V Limited1704(L)-32,990,466(L)16,146,334(L)2.09
31/03/2026Vivo Capital Fund VIII, L.P.1201(L)-90,718,100(L)0(L)0.00
31/03/2026Success Growth Limited1704(L)-32,990,466(L)16,146,334(L)2.09
31/03/2026Advantech Capital II Master Investment Limited1704(L)-32,990,466(L)16,146,334(L)2.09
31/03/2026Golden Sage Investments Limited1704(L)-32,990,466(L)16,146,334(L)2.09
31/03/2026Advantech Capital Partners II Limited1704(L)-32,990,466(L)16,146,334(L)2.09
31/03/2026Advantech Capital II L.P.1704(L)-32,990,466(L)16,146,334(L)2.09
31/03/2026Vivo Capital LLC1205(L)-103,245,000(L)0(L)0.00
31/03/2026WuXi Biologics (Cayman) Inc.1101(L)+11,370,590(L)475,069,724(L)61.47
31/03/2026WuXi XDC Cayman Inc.1101(L)+11,370,590(L)475,069,724(L)61.47
31/03/2026Vivo Capital VIII, LLC1205(L)-103,245,000(L)0(L)0.00
31/03/2026彭其前1704(L)-32,990,466(L)16,146,334(L)2.09
24/03/2026Chengwei Evergreen Capital, LP1704(L)-54,230,800(L)0(L)0.00
24/03/2026Chengwei Evergreen Management, LLC1704(L)-54,230,800(L)0(L)0.00
17/03/2026WuXi Biologics (Cayman) Inc.1001(L)+463,672,734(L)463,672,734(L)60.00
17/03/2026WuXi XDC Cayman Inc.1001(L)+463,672,734(L)463,672,734(L)60.00
 1  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.